Relating the Geno to the Pheno
Health data analytics seek to unravel the biology behind Alzheimer’s and Schizophrenia
James Strachan |
Finding links between genetic markers and the end phenotype can be difficult – especially with complex diseases, such as Alzheimer’s and Schizophrenia, where a multitude of other environmental factors affect disease development. In an attempt to close the gap, researchers from the University of Pittsburgh and Pfizer have announced a collaboration that aims to create a statistical model that relates brain scan data to genetic profiles (1). We spoke with Kayhan Batmanghelich, principle investigator and Assistant Professor in the Department of Biomedical Informatics in the School of Medicine, to tell us more about the collaboration.
In recent times, the budget of the NIH has remained constant while the number of scientists has increased, meaning that budget per capita has decreased. It’s important to think outside the box to obtain other sources of funding. When we presented the project to Pfizer, they confirmed that they had similar issues that needed resolving. Why not combine resources and make things more efficient? I think there’s a trend towards greater openness and collaboration in research that will inevitably lead to more innovation on the industry side, as well as greater opportunities for academia in terms of funding.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.